XML 32 R109.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information - Operating Results Information for Each Reportable Segment (Detail) (USD $)
3 Months Ended 12 Months Ended
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 27, 2013
Sep. 27, 2013
Jun. 28, 2013
Mar. 29, 2013
Dec. 28, 2012
Sep. 26, 2014
Sep. 27, 2013
Sep. 28, 2012
Segment Reporting Information [Line Items]                      
Revenues $ 812,100,000 $ 747,700,000 $ 778,500,000 [1] $ 711,500,000 $ 769,900,000 $ 726,200,000 $ 768,400,000 $ 678,400,000 $ 3,049,800,000 $ 2,942,897,000 $ 2,807,015,000
Operating Earnings                 571,155,000 [2] 608,890,000 [2] 594,074,000 [2]
Depreciation & Amortization                 62,500,000 62,900,000 61,000,000
Total Assets 3,357,290,000       3,468,474,000       3,357,290,000 3,468,474,000 2,878,700,000
Corporate
                     
Segment Reporting Information [Line Items]                      
Operating Earnings                 (41,500,000) [2] (22,300,000) [2] (9,600,000) [2]
Depreciation & Amortization                 22,000,000 25,900,000 23,800,000
Total Assets 1,333,000,000       1,574,900,000       1,333,000,000 1,574,900,000 1,081,000,000
Operating Segments | Oncology Systems
                     
Segment Reporting Information [Line Items]                      
Revenues                 2,344,200,000 2,252,700,000 2,189,500,000
Operating Earnings                 495,500,000 [2] 512,000,000 [2] 505,400,000 [2]
Depreciation & Amortization                 24,800,000 21,000,000 22,900,000
Total Assets 1,314,100,000       1,217,000,000       1,314,100,000 1,217,000,000 1,220,100,000
Operating Segments | Imaging Components
                     
Segment Reporting Information [Line Items]                      
Revenues                 660,200,000 641,900,000 580,400,000
Operating Earnings                 169,900,000 [2] 165,600,000 [2] 142,500,000 [2]
Depreciation & Amortization                 14,700,000 14,600,000 12,300,000
Total Assets 431,600,000       398,500,000       431,600,000 398,500,000 356,100,000
Operating Segments | Total Reportable Segments
                     
Segment Reporting Information [Line Items]                      
Revenues                 3,004,400,000 2,894,600,000 2,769,900,000
Operating Earnings                 665,400,000 [2] 677,600,000 [2] 647,900,000 [2]
Depreciation & Amortization                 39,500,000 35,600,000 35,200,000
Total Assets 1,745,700,000       1,615,500,000       1,745,700,000 1,615,500,000 1,576,200,000
Operating Segments | Other
                     
Segment Reporting Information [Line Items]                      
Revenues                 45,400,000 48,300,000 37,100,000
Operating Earnings                 (52,700,000) [2] (46,400,000) [2] (44,200,000) [2]
Depreciation & Amortization                 1,000,000 1,400,000 2,000,000
Total Assets $ 278,600,000       $ 278,100,000       $ 278,600,000 $ 278,100,000 $ 221,500,000
[1] In the second fiscal quarter of 2014, net earnings include a $25.1 million litigation charge related to a settlement agreement with the University of Pittsburgh.
[2] Operating earnings of reportable segments and Other include an allocation of corporate expenses based on a percentage of their sales.